Security key
G9495L125
Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (VRAX)
CUSIP: G9495L125
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Ordinary shares, par value $0.001 per share
- Total 13F shares
- 919,547
- Total 13F value
- $202,209
- Share change
- +884,588
- SEC-reported price per share
- $0.22
- Number of holders
- 3
- Value change
- +$190,127
- Number of buys
- 2
- Number of sells
- 4
- Shares outstanding
- 20,044,870
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
3
Top holders
3
VRAX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Virax Biolabs Group Ltd SEC filings
Virax Biolabs Group Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G9495L125
Recent filing periods:
Ownership snapshot
Top reported holders of VRAX - Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
James Alexander Cunliffe ...
Disclosed value leader
James Alexander Cunliffe ...
Comparable rows
7/8
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 8.3%
1 rows are not safely comparable across share classes.
13D/G row: James Alexander Cunliffe Foster
Showing 1-6 of 8 holder rows.
Quick read
James Alexander Cunliffe Foster leads the comparable SEC ownership view at 8.3%.
7 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens James Alexander Cunliffe Foster's linked filing trail.
Comparable ownership
Top 5
James Alexander Cunliffe Foster
8.3%
ARMISTICE CAPITAL, LLC
5%
XTX Topco Ltd
0.11%
UBS Group AG
0.04%
NATIONAL BANK OF CANADA /FI/
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| James Alexander Cunliffe Foster |
13D/G
3/4/5
James Foster · Chief Executive Officer
|
8.3%
|
$232,199
368,570 shares
|
+$30,634 | 31 Mar 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$170,041
1,000,239 shares
|
+$29,976 | 31 Mar 2026 |
| XTX Topco Ltd |
13F
Company
|
0.11%
|
$7,413
21,437 shares
|
— | 31 Dec 2025 |
| UBS Group AG |
13F
Company
|
0.04%
|
$2,592
7,492 shares
|
— | 31 Dec 2025 |
| NATIONAL BANK OF CANADA /FI/ |
13F
Company
|
0.03%
|
$2,070
6,000 shares
|
— | 31 Dec 2025 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
0%
|
$7
20 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
919,547
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
5
Q1 2026 holders
3
Holder diff
-2
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend